Overview

Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 Diabetes

Status:
Completed

Trial end date:
2004-11-01

Target enrollment:

Participant gender:

Summary

The study investigated the effect of rosiglitazone and placebo on carotid intima media thickness in patients with insulin resistance syndrome and/or type 2 diabetes.

Phase:

Phase 4

Details

Lead Sponsor:

GlaxoSmithKline

Treatments:

Insulin
Rosiglitazone